Alivus Life Sciences Limited — Important, 22-10-2024: General Updates

Glenmark Life Sciences Limited has received approval from the BSE and NSE to reclassify Glenmark Pharmaceuticals Limited and Mr. Glenn Mario Saldanha from the 'Promoter Group' category to 'Public Shareholders.' This change is effective immediately and will reflect in the company's future shareholding patterns. The decision aligns with Regulation 31A of SEBI's Listing Regulations.